Patent ID: 7838034

Claim:
A method of administering a pharmaceutically active compound to a patient in need thereof comprising intravenously administering a therapeutically effective amount of the active compound to the patient in the form of a dosage form, said dosage form comprising a combination of (a) undissolved particles consisting of one or more pharmaceutical active compounds suspended in (b) a water-based suspending medium, wherein (i) the undissolved particles have an average particle size of ≧5 μm. (ii) at least 80% of the total mass of undissolved particles is made up of undissolved particles having a particle size ranging from >2 μm up to 100 μm, (iii) the dosage form is in a form suitable for intravenous administration, and (iv) the dosage form exhibits the property that when the dosage form is intravenously administered to a patient then any undissolved particle entering the patient's body dissolves during a period of time, wherein that period of time is defined as the time required for said particle to travel intravenously from a first point to a second point within the patient's body, wherein the first point is defined as the point at which said particle is intravenously introduced into the patient's bloodstream, and the second point is defined as the point at which said particle, traveling in the patient's bloodstream, first exits from the patient's heart.